Fast and Flexible mRNA Vaccine Manufacturing as a Solution to Pandemic Situations by Adopting Chemical Engineering Good Practice—Continuous Autonomous Operation in Stainless Steel Equipment Concepts
SARS-COVID-19 vaccine supply for the total worldwide population has a bottleneck in manufacturing capacity. Assessment of existing messenger ribonucleic acid (mRNA) vaccine processing shows a need for digital twins enabled by process analytical technology approaches in order to improve process trans...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/36df35f292794daaa354e627e9a63b18 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:36df35f292794daaa354e627e9a63b18 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:36df35f292794daaa354e627e9a63b182021-11-25T18:49:58ZFast and Flexible mRNA Vaccine Manufacturing as a Solution to Pandemic Situations by Adopting Chemical Engineering Good Practice—Continuous Autonomous Operation in Stainless Steel Equipment Concepts10.3390/pr91118742227-9717https://doaj.org/article/36df35f292794daaa354e627e9a63b182021-10-01T00:00:00Zhttps://www.mdpi.com/2227-9717/9/11/1874https://doaj.org/toc/2227-9717SARS-COVID-19 vaccine supply for the total worldwide population has a bottleneck in manufacturing capacity. Assessment of existing messenger ribonucleic acid (mRNA) vaccine processing shows a need for digital twins enabled by process analytical technology approaches in order to improve process transfer for manufacturing capacity multiplication, a reduction in out-of-specification batch failures, qualified personal training for faster validation and efficient operation, optimal utilization of scarce buffers and chemicals and speed-up of product release by continuous manufacturing. In this work, three manufacturing concepts for mRNA-based vaccines are evaluated: Batch, full-continuous and semi-continuous. Technical transfer from batch single-use to semi-continuous stainless-steel, i.e., plasmid deoxyribonucleic acid (pDNA) in batch and mRNA in continuous operation mode, is recommended, in order to gain: faster plant commissioning and start-up times of about 8–12 months and a rise in dose number by a factor of about 30 per year, with almost identical efforts in capital expenditures (CAPEX) and personnel resources, which are the dominant bottlenecks at the moment, at about 25% lower operating expenses (OPEX). Consumables are also reduceable by a factor of 6 as outcome of this study. Further optimization potential is seen at consequent digital twin and PAT (Process Analytical Technology) concept integration as key-enabling technologies towards autonomous operation including real-time release-testing.Axel SchmidtHeribert HelgersFlorian Lukas VetterAlex JuckersJochen StrubeMDPI AGarticlemRNApDNASARS-COVID-19vaccinesdigital twinprocess analytical technologyChemical technologyTP1-1185ChemistryQD1-999ENProcesses, Vol 9, Iss 1874, p 1874 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
mRNA pDNA SARS-COVID-19 vaccines digital twin process analytical technology Chemical technology TP1-1185 Chemistry QD1-999 |
spellingShingle |
mRNA pDNA SARS-COVID-19 vaccines digital twin process analytical technology Chemical technology TP1-1185 Chemistry QD1-999 Axel Schmidt Heribert Helgers Florian Lukas Vetter Alex Juckers Jochen Strube Fast and Flexible mRNA Vaccine Manufacturing as a Solution to Pandemic Situations by Adopting Chemical Engineering Good Practice—Continuous Autonomous Operation in Stainless Steel Equipment Concepts |
description |
SARS-COVID-19 vaccine supply for the total worldwide population has a bottleneck in manufacturing capacity. Assessment of existing messenger ribonucleic acid (mRNA) vaccine processing shows a need for digital twins enabled by process analytical technology approaches in order to improve process transfer for manufacturing capacity multiplication, a reduction in out-of-specification batch failures, qualified personal training for faster validation and efficient operation, optimal utilization of scarce buffers and chemicals and speed-up of product release by continuous manufacturing. In this work, three manufacturing concepts for mRNA-based vaccines are evaluated: Batch, full-continuous and semi-continuous. Technical transfer from batch single-use to semi-continuous stainless-steel, i.e., plasmid deoxyribonucleic acid (pDNA) in batch and mRNA in continuous operation mode, is recommended, in order to gain: faster plant commissioning and start-up times of about 8–12 months and a rise in dose number by a factor of about 30 per year, with almost identical efforts in capital expenditures (CAPEX) and personnel resources, which are the dominant bottlenecks at the moment, at about 25% lower operating expenses (OPEX). Consumables are also reduceable by a factor of 6 as outcome of this study. Further optimization potential is seen at consequent digital twin and PAT (Process Analytical Technology) concept integration as key-enabling technologies towards autonomous operation including real-time release-testing. |
format |
article |
author |
Axel Schmidt Heribert Helgers Florian Lukas Vetter Alex Juckers Jochen Strube |
author_facet |
Axel Schmidt Heribert Helgers Florian Lukas Vetter Alex Juckers Jochen Strube |
author_sort |
Axel Schmidt |
title |
Fast and Flexible mRNA Vaccine Manufacturing as a Solution to Pandemic Situations by Adopting Chemical Engineering Good Practice—Continuous Autonomous Operation in Stainless Steel Equipment Concepts |
title_short |
Fast and Flexible mRNA Vaccine Manufacturing as a Solution to Pandemic Situations by Adopting Chemical Engineering Good Practice—Continuous Autonomous Operation in Stainless Steel Equipment Concepts |
title_full |
Fast and Flexible mRNA Vaccine Manufacturing as a Solution to Pandemic Situations by Adopting Chemical Engineering Good Practice—Continuous Autonomous Operation in Stainless Steel Equipment Concepts |
title_fullStr |
Fast and Flexible mRNA Vaccine Manufacturing as a Solution to Pandemic Situations by Adopting Chemical Engineering Good Practice—Continuous Autonomous Operation in Stainless Steel Equipment Concepts |
title_full_unstemmed |
Fast and Flexible mRNA Vaccine Manufacturing as a Solution to Pandemic Situations by Adopting Chemical Engineering Good Practice—Continuous Autonomous Operation in Stainless Steel Equipment Concepts |
title_sort |
fast and flexible mrna vaccine manufacturing as a solution to pandemic situations by adopting chemical engineering good practice—continuous autonomous operation in stainless steel equipment concepts |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/36df35f292794daaa354e627e9a63b18 |
work_keys_str_mv |
AT axelschmidt fastandflexiblemrnavaccinemanufacturingasasolutiontopandemicsituationsbyadoptingchemicalengineeringgoodpracticecontinuousautonomousoperationinstainlesssteelequipmentconcepts AT heriberthelgers fastandflexiblemrnavaccinemanufacturingasasolutiontopandemicsituationsbyadoptingchemicalengineeringgoodpracticecontinuousautonomousoperationinstainlesssteelequipmentconcepts AT florianlukasvetter fastandflexiblemrnavaccinemanufacturingasasolutiontopandemicsituationsbyadoptingchemicalengineeringgoodpracticecontinuousautonomousoperationinstainlesssteelequipmentconcepts AT alexjuckers fastandflexiblemrnavaccinemanufacturingasasolutiontopandemicsituationsbyadoptingchemicalengineeringgoodpracticecontinuousautonomousoperationinstainlesssteelequipmentconcepts AT jochenstrube fastandflexiblemrnavaccinemanufacturingasasolutiontopandemicsituationsbyadoptingchemicalengineeringgoodpracticecontinuousautonomousoperationinstainlesssteelequipmentconcepts |
_version_ |
1718410640796680192 |